EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tumoral Metabolism at the Intersection of Oncogene Signaling, Epigenetics and Immunology: Emerging Therapeutic Strategies in Cancer

Bhoomendra A Bhongade iD, Areeg Anwer Ali iD, Mohamed El-Tanani, Shakta Mani Satyam, Sirajunisa Talath iD, Adil Farooq Wali iD, Syed Arman Rabbani iD, Walaa Ibraheem, Karolina Hoffmann iD, Ashot Avagimyan, Ioannis Ilias iD, Sorina Ispas iD und 3 weitere

Current Issues in Molecular Biology · 15.07.2026 · 48 (7) · 723

DOI: 10.3390/cimb48070723 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 15.07.2026. Verfasst von Bhoomendra A Bhongade und 14 weiteren Autor:innen. Beteiligte Einrichtung: RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic reprogramming is a unifying characteristic of cancer and involves orchestrated changes in glucose, amino acid, lipid, and mitochondrial metabolism that go beyond the well-known Warburg effect. Evidence is accumulating that these metabolic states are actively remodeled by oncogene signaling and tumor suppressor loss, allowing cancer cells to sustain anabolic growth, redox homeostasis, and therapeutic stress. This review provides an overview of new findings on tumor metabolism, mechanisms, and the molecular networks governing this reprogramming. We discuss how the major oncogenic pathways, such as MYC, mTOR, HIF, and AMPK, reprogram metabolism using transcriptional, epigenetic, and post-translational control of metabolic flux. A focus is placed on mitochondrial bioenergetics, dynamics, and metabolite signaling such as cancer cell fitness and stress tolerance-defining factors. We also discussed metabolic crosstalk in the tumor ecosystem, including nutrient competition, metabolite coupling, and immunometabolic reprogramming to coordinate metabolism-mediated effects on tumorigenesis and therapeutic response. The review further considers the mechanistic basis for metabolism-targeted therapies, including pathway dependencies, adaptive responses, and micro-environmental context that constrain clinical benefit. Recent innovations such as spatial metabolomics, single-cell metabolic profiling, and systems-level models have unveiled significant intratumoral heterogeneity of metabolism, and they have provided important information about diverse vulnerabilities to therapeutic intervention. Accordingly, understanding the complex crosstalk between these metabolic networks is crucial to rationally designing combination strategies that selectively leverage cancer-specific metabolic liabilities with minimal toxicities against normal tissues.

Schlagwörter

Stichwörter der Autor:innen

Warburg effectmetabolic heterogeneitymetabolic reprogrammingmitochondrial dynamicstherapeutic targetingtumor metabolismtumor microenvironment

Autor:innen und Institutionen

  • RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.
  • RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.
  • Department and Clinic of Internal Diseases and Metabolic Disorders, Poznan University of Medical Sciences, 61-701 Poznań, Poland.
  • Department of Internal Diseases Propedeutics, Yerevan State Medical University After M. Heratsi, Yerevan 0025, Armenia.
  • Department of Endocrinology, Diabetes and Metabolism, Elena Venizelou Hospital, GR-11521 Athens, Greece.
  • Department of Anatomy, Faculty of General Medicine, "Ovidius" University, 900470 Constanta, Romania.

ORCID-Profile: Bhoomendra A Bhongade, Areeg Anwer Ali, Sirajunisa Talath, Adil Farooq Wali, Syed Arman Rabbani, Karolina Hoffmann, Ioannis Ilias, Sorina Ispas, Anna Paczkowska, Manfredi Rizzo

Zitieren

APA

Bhongade, B. A., Ali, A. A., El-Tanani, M., Satyam, S. M., Talath, S., Wali, A. F., Rabbani, S. A., Ibraheem, W., Hoffmann, K., Avagimyan, A., Ilias, I., Ispas, S., Maggio, V., Paczkowska, A., & Rizzo, M. (2026). Tumoral Metabolism at the Intersection of Oncogene Signaling, Epigenetics and Immunology: Emerging Therapeutic Strategies in Cancer. Current Issues in Molecular Biology, 48(7), 723. https://doi.org/10.3390/cimb48070723

Vancouver

Bhongade BA, Ali AA, El-Tanani M, Satyam SM, Talath S, Wali AF, et al. Tumoral Metabolism at the Intersection of Oncogene Signaling, Epigenetics and Immunology: Emerging Therapeutic Strategies in Cancer. Current Issues in Molecular Biology. 2026;48(7):723. doi:10.3390/cimb48070723

BibTeX
@article{Bhongade2026,
  author = {Bhongade, Bhoomendra A and Ali, Areeg Anwer and El-Tanani, Mohamed and Satyam, Shakta Mani and Talath, Sirajunisa and Wali, Adil Farooq and Rabbani, Syed Arman and Ibraheem, Walaa and Hoffmann, Karolina and Avagimyan, Ashot and Ilias, Ioannis and Ispas, Sorina and Maggio, Viviana and Paczkowska, Anna and Rizzo, Manfredi},
  title = {Tumoral Metabolism at the Intersection of Oncogene Signaling, Epigenetics and Immunology: Emerging Therapeutic Strategies in Cancer},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {7},
  pages = {723},
  doi = {10.3390/cimb48070723}
}
Kostenlos starten →